Menu

Blog

Mar 28, 2020

U.S. Approves Abbott Labs Five-Minute ‘Rapid’ Coronavirus Test

Posted by in category: biotech/medical

Abbott Laboratories won U.S. Food and Drug Administration approval for its molecular test for the Coronavirus strain COVID-19, which the company says can deliver “positive results in as little as five minutes and negative results in 13 minutes.”

The FDA’s “emergency use authorization” awarded to Abbott’s ID NOW COVID-19 test is the latest in a growing number of agency approvals for more rapid molecular “point-of-care” diagnostic tests that can be used in temporary screening locations, doctor’s office labs and nursing homes to detect the Coronavirus strain COVID-19 within a half hour.

“With rapid testing on ID NOW, healthcare providers can perform molecular point-of-care testing outside the traditional four walls of a hospital in outbreak hotspots,” Abbott president and chief operating officer Robert Ford said.

Comments are closed.